Archangels

Cytomos, an Edinburgh-based biotechnology company, has raised £5 million to scale up production of its unique cell analysis technology. The oversubscribed funding round was led by existing investors Archangels with participation from Old College Capital, Scottish Enterprise and British Busines

Edinburgh-based B2B software as a service (SaaS) learning and training management software provider Administrate Limited has completed a £3.05 million funding round. A £1m investment was provided by the Investment Fund for Scotland (IFS), Equity Finance, managed by Maven Capital Partners

Stirling-based nanomaterial producer iGii has secured £8.8 million in new funding to accelerate growth. The funding round was led by a £4m injection from the Scottish National Investment Bank, with a further £4.8m coming from existing iGii shareholders Archangel Investors and Par E

Scottish businessman and angel investor Barry Sealey, co-founder of Edinburgh-based Archangel Investors, has passed away. Mr Sealey, a "true pioneer" in angel investing, launched Archangels with Mike Rutterford in 1992.

Edinburgh-based biotechnology firm, Calcivis, has secured £5 million in funding to roll out its innovative dental technology. The firm’s patented system enables early detection of tooth decay – which in turn can enable timely preventive treatment – by deploying a biologic dia

Archangels invested more than £13.8 million during 2023 in eleven of Scotland’s best early-stage tech and life science companies. The total investment for 2023 among 11 businesses represents a small increase on Archangels’ investment activity in 2022 (£13.4m).

1nhaler, a Scotland-based drug delivery device developer, has raised £2 million to develop its unique single-use dry powder inhaler (DPI). The funding round was led by Archangels with support from Dr Yusuf Hamied, British Business Investments (BBI) and seed investors. Dr Hamied, non-executive

Glasgow-based integrated drug formulation and clinical trials specialist BDD has secured a fresh £2 million investment to fuel its expansion, responding to a surge in demand for its proprietary drug delivery technology and its niche clinical trial services. This funding initiative was led by p

Edinburgh-based life science firm Cytomos has successfully raised £4 million in a recent investment round for the development and market-testing of its Cytomos Dielectric Spectroscopy (CDS) technology. Archangels led this funding initiative with participation from notable investors such as Old

Scottish business angel syndicate Archangels has secured a £12 million co-investment agreement with British Business Investments through its Regional Angels Programme. The deal is set to empower the Edinburgh-based syndicate, which specialises in early-stage Scottish life sciences and technolo

Edinburgh-based enterprise training platform Administrate has secured a £5 million investment round from current backers Archangels, Mercia, and the Scottish National Investment Bank, with Hambro Perks joining the round as a fresh capital partner. The funding will fuel Administrate's rapid exp

Archangels, the Edinburgh-based business angel syndicate, has welcomed Daniel McKiddie as investment manager to its executive team, led by joint managing directors Niki McKenzie and David Ovens. Mr McKiddie, a chartered accountant, will work in tandem with Shaolei McKie, senior investment manager, t

Scottish technology firm Bioliberty has secured £2.2 million in funding to develop a unique soft robotic glove which can restore upper limb mobility in patients following a stroke. The funding round was led by business angel investment syndicate Archangels, with participation from Eos Adv

Edinburgh-based investment syndicate Archangels invested a total of £13.4 million in 11 early-stage tech and life science companies in Scotland in 2022. The total investment for 2022 among 11 businesses marks a 14% increase on Archangels’ investment activity in 2021 (11.8m).

Edinburgh-based healthtech company Hearing Diagnostics has completed a £1.1 million funding round and is now eyeing commercialisation in the domestic and US markets. Led by angel investment syndicate Archangels, the funding will unlock the spatial hearing screening technology’s market po